Zymeworks
ZYME
47 hedge funds and large institutions have $184M invested in Zymeworks in 2019 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 9 closing their positions.
11,950% more call options, than puts
Call options by funds: $482K | Put options by funds: $4K
114% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 7
44% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 9
39% more capital invested
Capital invested by funds: $132M → $184M (+$51.6M)
9% more funds holding
Funds holding: 43 → 47 (+4)
7.14% more ownership
Funds ownership: 28.42% → 35.56% (+7.1%)
Top Buyers
Top Sellers
| 1 |
Jane Street
New York
|
-$1.13M |
| 2 |
FI
Fosun International
Hong Kong,
China
|
-$1.03M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$775K |
| 4 |
Morgan Stanley
New York
|
-$488K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$417K |
ZYME Hedge Fund Activity: Q1 2019 in Review
47 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q1 2019, worth a combined $184M — up 39% from $132M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new ZYME positions and 9 closed out — a net gain of 4 holders — while 15 added to existing stakes and 7 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $28.6M. The largest seller was Jane Street, exiting entirely with an estimated $1.13M sold.
- 47 institutional investors held Zymeworks (ZYME) as of Q1 2019, up from 43 in Q4 2018.
- Funds reported $184M of Zymeworks stock for Q1 2019, up 39% quarter-over-quarter.
- 13 funds opened new Zymeworks positions in Q1 2019 and 9 closed out, a net change of +4 holders.
- The largest Zymeworks buyer in Q1 2019 was Fidelity Investments, an estimated $28.6M added.
- The largest Zymeworks seller in Q1 2019 was Jane Street, an estimated $1.13M sold.
Based on aggregated 13F filings for Q1 2019.